Quadrant Capital Group’s GoodRx Holdings GDRX Stock Holding History

Quadrant Capital Group’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-42	Closed	-$232	–	2720
2023 Q2	$232	Buy	+42	New	+$226	﹤0.01%	2645

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SQN Investors Menlo Park, California $12.8M AUM

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Quadrant Capital Group's GDRX Position: Q3 2023 in Review

Quadrant Capital Group sold out of GoodRx Holdings (GDRX) in Q3 2023, closing a stake of 42 shares — an estimated $232 sold.

Quadrant Capital Group first reported a position in GDRX in Q2 2023 and held it in 1 quarter. The position peaked at $232 in Q2 2023. 155 funds tracked by Wall St. Rank hold GDRX as of Q3 2023.

Quadrant Capital Group reported no remaining GoodRx Holdings position as of Q3 2023 after selling out during the quarter.
Quadrant Capital Group sold 42 GoodRx Holdings shares in Q3 2023, an estimated $232.
Quadrant Capital Group first reported a position in GoodRx Holdings in Q2 2023 and held it in 1 quarter.
Quadrant Capital Group's GoodRx Holdings position peaked at $232 in Q2 2023.
155 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2023.

Based on Quadrant Capital Group's 13F filing for Q3 2023, filed 14 Nov 2023.